HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.

Abstract
Matrix 2 protein ectodomain (M2e) is considered a promising candidate for a broadly protective influenza vaccine. M2e-based vaccines against human influenza A provide only partial protection against avian influenza viruses because of differences in the M2e sequences. In this work, we evaluated the possibility of obtaining equal protection and immune response by using recombinant protein on the basis of flagellin as a carrier of the M2e peptides of human and avian influenza A viruses. Recombinant protein was generated by the fusion of two tandem copies of consensus M2e sequence from human influenza A and two copies of M2e from avian A/H5N1 viruses to flagellin (Flg-2M2eh2M2ek). Intranasal immunisation of Balb/c mice with recombinant protein significantly elicited anti-M2e IgG in serum, IgG and sIgA in BAL. Antibodies induced by the fusion protein Flg-2M2eh2M2ek bound efficiently to synthetic peptides corresponding to the human consensus M2e sequence as well as to the M2e sequence of A/Chicken/Kurgan/05/05 RG (H5N1) and recognised native M2e epitopes exposed on the surface of the MDCK cells infected with A/PR/8/34 (H1N1) and A/Chicken/Kurgan/05/05 RG (H5N1) to an equal degree. Immunisation led to both anti-M2e IgG1 and IgG2a response with IgG1 prevalence. We observed a significant intracellular production of IL-4, but not IFN-γ, by CD4+ T-cells in spleen of mice following immunisation with Flg-2M2eh2M2ek. Immunisation with the Flg-2M2eh2M2ek fusion protein provided similar protection from lethal challenge with human influenza A viruses (H1N1, H3N2) and avian influenza virus (H5N1). Immunised mice experienced significantly less weight loss and decreased lung viral titres compared to control mice. The data obtained show the potential for the development of an M2e-flagellin candidate influenza vaccine with broad spectrum protection against influenza A viruses of various origins.
AuthorsLiudmila A Stepanova, Roman Y Kotlyarov, Anna A Kovaleva, Marina V Potapchuk, Alexandr V Korotkov, Mariia V Sergeeva, Marina A Kasianenko, Victor V Kuprianov, Nikolai V Ravin, Liudmila M Tsybalova, Konstantin G Skryabin, Oleg I Kiselev
JournalPloS one (PLoS One) Vol. 10 Issue 3 Pg. e0119520 ( 2015) ISSN: 1932-6203 [Electronic] United States
PMID25799221 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Viral
  • Epitopes
  • FLG protein, human
  • Filaggrin Proteins
  • Influenza Vaccines
  • M2 protein, Influenza A virus
  • Peptide Fragments
  • Recombinant Fusion Proteins
  • Viral Matrix Proteins
  • Flagellin
Topics
  • Animals
  • Antibodies, Viral (blood)
  • Blotting, Western
  • Enzyme-Linked Immunosorbent Assay
  • Epitopes (immunology)
  • Female
  • Filaggrin Proteins
  • Flagellin (immunology)
  • Humans
  • Immunization
  • Influenza A virus (immunology)
  • Influenza Vaccines (immunology)
  • Influenza, Human (immunology, prevention & control, virology)
  • Lung (immunology, virology)
  • Mice
  • Mice, Inbred BALB C
  • Orthomyxoviridae Infections (immunology, prevention & control, virology)
  • Peptide Fragments (genetics, immunology)
  • Recombinant Fusion Proteins (administration & dosage, genetics, immunology)
  • Viral Load
  • Viral Matrix Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: